The relative health hazard of each of the symptoms is unknown. Patients should be monitored closely and symptoms treated when appropriate. Most physicians do not now advise discontinuing a successful protease inhibitor-containing regimen when metabolic abnormalities emerge. Reproduced with permission. Inc. All rights reserved.
Noncommercial reproduction is encouraged.
Subscription lists are kept confidential. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only.